Medicare’s Hospital Insurance Trust Fund, which pays for inpatient hospital care under Part A, is projected to run out of reserves in 2033. That’s the date from the 2025 Trustees Report, and it moved up three years from the previous estimate of 2036. But “running out” doesn’t mean Medicare disappears. It means the program would only be able to cover a portion of Part A hospital bills using incoming payroll tax revenue, not the full amount.
The rest of Medicare, including doctor visits (Part B) and prescription drugs (Part D), faces no such deadline. Those programs are funded differently and can’t become insolvent the way Part A can.
What 2033 Actually Means
The Medicare Hospital Insurance Trust Fund works like a checking account with money flowing in and out. Right now, it’s roughly in balance. The Trustees expect small surpluses through 2027, with total income of about $457 billion slightly exceeding $450 billion in costs for 2025. Starting in 2028, spending will outpace revenue, and the fund will begin drawing down its reserves. By 2033, those reserves hit zero.
At that point, Medicare wouldn’t stop paying hospital claims. It would still collect payroll taxes every pay period, and that incoming revenue would cover a significant share of Part A costs. Based on recent KFF estimates for a comparable depletion scenario, incoming revenue would cover roughly 89 percent of scheduled Part A benefits. The remaining 11 percent gap is the real problem: without congressional action, hospitals, skilled nursing facilities, and home health agencies could face automatic payment cuts of about 11 cents on every dollar.
No one in Congress, from either party, has ever allowed that to happen. Every time the trust fund has approached depletion in the past, lawmakers have intervened with some combination of tax changes, spending reforms, or structural adjustments.
Why Part B and Part D Are Different
Only Part A depends on a trust fund that can be exhausted. Parts B and D use a completely different funding model. Beneficiary premiums cover about one quarter of their costs, and the federal Treasury’s general revenues fill the rest automatically. Because the Treasury always makes up the difference, these parts of Medicare can never become insolvent in the technical sense. Their costs still rise, and that spending puts pressure on the federal budget, but there’s no depletion clock ticking.
Why the Date Keeps Shifting
If 2033 sounds alarming, it helps to know that Medicare’s projected “expiration date” has been moving around for decades, and it has almost always been pushed further into the future before it arrives. In 1980, the Trustees projected the fund would be insolvent by 1994. In 2012, the estimate was that the fund would be exhausted right around now. Neither happened.
Policy changes are the biggest reason these dates shift. The Affordable Care Act in 2010 extended the projected depletion date by 12 years in a single stroke. Strong economic growth has also helped: in the 2000 report, robust job numbers and lower-than-expected spending pushed the date out by a full decade, to 2025. Conversely, recessions, pandemics, or higher-than-expected healthcare costs can pull the date closer, which is part of why the 2025 report moved it from 2036 to 2033.
What’s Driving Costs Up
Three forces are pushing Medicare spending higher, and they reinforce each other.
The first is demographics. About 10,000 baby boomers have been turning 65 every day for more than a decade, swelling Medicare enrollment. An aging population moderately increases spending on acute hospital care and strongly increases spending on long-term care. More enrollees drawing benefits while a relatively smaller workforce pays in creates a structural gap.
The second is medical technology. New treatments, devices, imaging tools, and surgical techniques improve care but also raise costs. Research consistently identifies advances in medical technology as the single largest driver of healthcare spending growth, even more than aging itself. And the two factors compound each other: an older population uses more of the expensive new treatments.
The third is healthcare prices. Health care is labor-intensive, and productivity gains in medicine don’t keep pace with the broader economy. This means the relative price of healthcare tends to rise over time, a phenomenon economists call Baumol’s cost disease. The effect on spending growth is roughly as large as the effect of population aging alone.
Where the Money Comes From
About three quarters of the Hospital Insurance Trust Fund’s income comes from the Medicare payroll tax, which is 1.45 percent of wages for both employees and employers (2.9 percent total). High earners pay an additional 0.9 percent on wages above $200,000. Roughly one eighth of the fund’s income comes from income taxes on Social Security benefits, with the remainder from smaller sources like interest on the fund’s reserves.
The core math problem is straightforward: the payroll tax brings in a relatively fixed percentage of national wages, while healthcare spending grows faster than wages do. Over time, that gap widens.
What Congress Could Do
Lawmakers have a range of tools to close the gap, and most analyses suggest relatively modest changes could extend solvency for decades.
On the revenue side, increasing the Medicare payroll tax by just 1 percentage point (split between employers and workers) would generate roughly $1.3 trillion over ten years. That’s more than twice what’s needed to close the projected funding gap in 2032. A smaller, more targeted change, like expanding the base of the net investment income tax so it covers more types of investment earnings, could close about 40 percent of the gap on its own.
On the spending side, options include negotiating lower payment rates for hospitals and post-acute care providers, adjusting how Medicare pays for certain services, or shifting more costs to higher-income beneficiaries. Some analysts have also proposed converting Part A to the same general-revenue funding model used for Parts B and D, which would eliminate the solvency question entirely, though it would shift costs to the broader federal budget.
The most likely outcome, based on every previous episode in Medicare’s history, is some combination of revenue increases and spending adjustments passed before the trust fund actually runs dry. The political pressure to act becomes intense as the deadline approaches, because allowing automatic cuts to hospital payments would destabilize the healthcare system for tens of millions of people. The question isn’t really whether Congress will act, but when and how.